Menu
Recruiting NCT04415983

Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children

Phase III Interventional Helicobacter Pylori Infection

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Nitazoxanide, Clarithromycin, Metronidazole, Proton pump inhibitor.
Who it may be relevant to
Registry conditions: Helicobacter Pylori Infection. Basic parameters: up to 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Study of Novel Triple Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori in Children

Overview

Study of Nitazoxanide (NTZ) based therapeutic regimens for Helicobacter pylori in children

Detailed description

Study of Novel triple Nitazoxanide (NTZ) based new therapeutic regimens for Helicobacter pylori in children

Interventions

  • Drug Nitazoxanide
    Nitazoxanide twice daily
  • Drug Clarithromycin
    Klacid twice daily
  • Drug Metronidazole
    Metronidazole twice daily
  • Drug Proton pump inhibitor
    Omeprazoe twice daily

Primary outcome measures

  • Number of patients with cured helicobacter infection [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

\- Positive helicobacter infection.

Exclusion criteria

  • Previous treatment for H. Pylori.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Triple blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Sherief Abd-Elsalam — Tanta

Identifiers

NCT: NCT04415983 · helicobacter children

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗